Hong Kong stock market anomaly | Lai Ka Pharmaceutical-B (02105.HK) rose more than 4% in the morning. The human clinical data of LAE102 will be disclosed for the first time at the ADA 2025 conference.

According to the China Fortune Financial News app, the stock of Lai Kai Pharmaceutical-B (02105.HK) surged by over 4% in the morning, rising by 4.07% to 19.94 Hong Kong dollars, with a turnover of 133 million Hong Kong dollars as of the time of publication.